Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis

European Heart Journal

12 December 2025

Organised by:

Abstract

AbstractBackground and Aims

Blood pressure (BP) lowering reduces cardiovascular disease (CVD) risk; however, the benefits of treating patients with normal systolic BP but elevated diastolic BP remain uncertain.

Methods

Data from 51 randomized controlled trials were pooled to compare BP-lowering effects in participants with and without isolated diastolic hypertension (IDH), defined as systolic BP < 130 mmHg and diastolic BP ≥ 80 mmHg. Treatment effects were stratified across baseline diastolic BP categories (range < 60 to ≥90 mmHg) among individuals with baseline systolic BP < 130 mmHg. Fixed-effect one-stage individual participant data meta-analyses were used, and Cox proportional hazard models, stratified by trial, were applied to analyse the data.

Results

Among 358 325 participants, 15 845 (4.4%) had IDH. At a median follow-up of 4.2 years, a 5 mmHg reduction in systolic BP reduced the risk of major cardiovascular events similarly in individuals with IDH [hazard ratio 0.91; 95% confidence interval (CI) 0.82–1.01] and those without IDH (hazard ratio 0.90; 95% CI 0.89–0.92; P for interaction = 1.00). Analyses by baseline diastolic BP showed no evidence of heterogeneity in treatment effects among individuals with baseline systolic BP < 130 mmHg (P for interaction = .26). Relative treatment effects were not statistically different by CVD history, age, prior medication use, and BP measurement methods.

Conclusions

The study found no evidence to suggest that pharmacological BP-lowering therapy in individuals with IDH is less or more effective than in those without IDH. Relative risk reductions also did not diminish in those with lower diastolic BP, down to <60 mmHg at baseline. No meaningful differences across various clinical phenotypes were detected.

Contributors

You may be interested in

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

Trend in the prevalence, awareness, treatment and control of hypertension among adult over in Nigeria over a 4-year period

Congress Presentation

Treadmill exercise test as a screening tool in the development of hypertension

ESC 365 is supported by

Explore sponsored resources